NVO

New York Stock Exchange

Novo Nordisk A/S · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$205.68B

PE Ratio

12.1742

EV to Ebitda

9.003

Earnings Yield

8.21%

Revenue (TTM)

$46.77B

Net Income (TTM)

$15.45B

Revenue (Annual YoY Growth)

10.97%

Revenue (Quarterly YoY Growth)

0.66%

Profit Margin

33.03%

Return on Equity

62.44%

Debt to Equity Ratio

0.6749

Dividend Yield

3.82%

All fundamentals

Core10 fields›

Market Cap$205.68B

Revenue TTM$46.77B

Shares Outstanding4.43B

Float4454079125

Float Short0.52%

Days To Cover0.9838191715

Short Interest16679048.0

Institutional Ownership10.63%

Relative Strength58.7

GARP355

Growth Estimates18 fields›

Revenue Growth (Annual)10.97%

Revenue Growth (Quarterly YoY)0.66%

Operating Revenue Growth (Annual)0.181502

Operating Revenue Growth (Quarterly YoY)0.23464

3-Year Revenue Growth23.19%

5-Year Revenue Growth19.21%

EPS Growth (Annual)6.13%

EPS Growth (Quarterly YoY)3.95%

3-Year EPS Growth Rate26.36%

5-Year EPS Growth Rate20.39%

LT EPS Growth Estimates4.09%

EBITDA Growth (Annual)5.50%

EBITDA Growth (Quarterly YoY)-6.71%

CFO Growth (Annual)2.66%

CFO Growth (Quarterly YoY)-33.74%

FCF Growth (Annual)-56.61%

Dividend Growth (Annual)8.79%

Dividend Growth (Quarterly YoY)11.81%

Operations28 fields›

Revenue TTM$46.77B

Gross Margin TTM80.90%

Gross Margin (Quarterly)80.86%

R&D % of Revenue TTM16.94%

R&D Expenses TTM$7.92B

Operating Margin TTM41.17%

Operating Margin (Quarterly)40.32%

Operating Expenses TTM$18.58B

Profit Margin TTM33.03%

Profit Margin (Quarterly)33.98%

Net Income TTM$15.45B

EPS TTM3.468

EPS (Quarterly)0.9419

EBIT Margin TTM41.17%

EBIT Margin (Quarterly)40.32%

EBITDA Margin TTM48.35%

EBITDA Margin (Quarterly)47.35%

EBITDA TTM$22.61B

CFO % of Revenue TTM38.54%

CFO % of Revenue (Quarterly)10.08%

CFO TTM$18.08B

Cash Margin31.34%

Capex % of Revenue TTM29.25%

Capital Expenditures$13.68B

FCF % of Revenue TTM9.38%

FCF % of Revenue (Quarterly)-44.16%

FCF TTM$4.40B

Fundamental Score9

Efficiency5 fields›

ROE62.44%

ROA20.46%

ROIC37.26%

CROCI10.62%

Stock Comp % TTM0.46%

Valuation21 fields›

P/E (TTM)12.1742

P/E Forward12.1901

P/E Ex-Cash11.8985

P/S Forward4.1737

PEG2.1555

PEG Forward-22.2011

P/CFO10.3975

P/FCF42.7

EV/EBITDA (TTM)9.003

EV/EBITDA Forward9.5066

EV/Revenues (TTM)4.3529

EV/Revenues Forward4.5382

EV/CFO13.4067

EV/FCF (TTM)46.2301

Price To Book8.0931

Price to Tangible Book70.1541

Earnings Yield8.21%

FCF Yield2.34%

Dividend Yield3.82%

Payout Ratio97.11%

Value Score9

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.1369

Relative Profit Margin (Quarterly)2.5815

Relative P/E0.4957

Relative P/S0.8541

Relative P/B1.2796

Relative Earnings Yield2.0175

Relative Dividend Yield1.2403

Relative ROE2.1124

Relative ROA2.1207

Relative ROIC2.5302

Relative Debt to Equity0.6832

Liquidity15 fields›

Cash Per Share1.2584

Current Ratio0.7996

Cash & ST Assets$4.24B

Total Debt$18.91B

Goodwill & Intangibles$20.45B

Total Assets$85.37B

Total Liabilities$54.85B

Shareholders Equity$23.13B

Debt to Equity0.6749

Debt to Assets24.12%

Interest Expense$1.48B

Times Interest Earned12.9716

CFO to Debt (TTM)1.0815

Debt to EBITDA (TTM)0.7395

Goodwill % of Assets23.96%

Yields5 fields›

Dividend Yield3.82%

Payout Ratio97.11%

Earnings Yield8.21%

Buyback Yield0.11%

Shareholder Yield2.42%

Options Flow8 fields›

Call Volume47091

Put Volume12960

Put/Call Ratio0.27521182391539784

Call $ Volume10647820

Put $ Volume1952761

Put/Call $ Ratio0.1833953804628553

Call OI952415

Put OI651157